
Neladalkib received accelerated approval for adults with advanced ALK-positive NSCLC after specified prior therapies, supported by durable responses in the ALKOVE-1 trial.
The NCPA is pleased to announce these upcoming online events for pharmacists and pharmacy team members.
ALEXANDRIA, Va. (Aug. 6, 2026) – The National Community Pharmacists Association is pleased to announce these upcoming online events for pharmacists and pharmacy team members:
Ongoing:
Events are subject to change. Visit our website for the latest information on NCPA events.






